ProBDNF promotes sepsis-associated encephalopathy in mice by dampening the immune activity of meningeal CD4+ T cells
Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive ass...
Saved in:
Published in | Journal of neuroinflammation Vol. 17; no. 1; pp. 169 - 17 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
28.05.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE.
Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg
)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice.
In the septic mice, cognitive function was impaired, the percentage of CD4
T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg
) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4
T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4
T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4
T cells in cultured splenocytes from septic mice (P = 0.0021).
Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4
T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. |
---|---|
AbstractList | Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Methods Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg−1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. Results In the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg−1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021). Conclusion Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg.sup.-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. In the septic mice, cognitive function was impaired, the percentage of CD4.sup.+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg.sup.-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4.sup.+ T cells. Intraperitoneal injection of McAb-proB (100 [mu]g) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4.sup.+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 [mu]g) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4.sup.+ T cells in cultured splenocytes from septic mice (P = 0.0021). Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4.sup.+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Methods Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg.sup.-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. Results In the septic mice, cognitive function was impaired, the percentage of CD4.sup.+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg.sup.-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4.sup.+ T cells. Intraperitoneal injection of McAb-proB (100 [mu]g) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4.sup.+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 [mu]g) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4.sup.+ T cells in cultured splenocytes from septic mice (P = 0.0021). Conclusion Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4.sup.+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. Keywords: Sepsis, Encephalopathy, Meningeal immunity, CD4.sup.+ T cells, Brain-derived neurotrophic factor precursor, Monoclonal antibody Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg )-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. In the septic mice, cognitive function was impaired, the percentage of CD4 T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg ) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4 T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4 T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4 T cells in cultured splenocytes from septic mice (P = 0.0021). Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4 T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. Abstract Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Methods Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg−1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. Results In the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg−1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021). Conclusion Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE.BACKGROUNDSepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE.Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice.METHODSFear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice.In the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021).RESULTSIn the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021).Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.CONCLUSIONUpregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. |
ArticleNumber | 169 |
Audience | Academic |
Author | Zhong, Feng Shen, Wei-Yun Luo, Cong Li, Hui Dai, Ru-Ping Hu, Zhao-Lan Luo, Ru-Yi |
Author_xml | – sequence: 1 givenname: Ru-Yi surname: Luo fullname: Luo, Ru-Yi – sequence: 2 givenname: Cong surname: Luo fullname: Luo, Cong – sequence: 3 givenname: Feng surname: Zhong fullname: Zhong, Feng – sequence: 4 givenname: Wei-Yun surname: Shen fullname: Shen, Wei-Yun – sequence: 5 givenname: Hui surname: Li fullname: Li, Hui – sequence: 6 givenname: Zhao-Lan surname: Hu fullname: Hu, Zhao-Lan – sequence: 7 givenname: Ru-Ping surname: Dai fullname: Dai, Ru-Ping |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32466783$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhSNURB_wB1ggS2yQUIrfTjZIZUqhUgUsytpynJsZjxI7xJ5K8-9xZlroVAhZsiP73M851-e0OPLBQ1G8JvickEp-iITWipeY4hKTSuT5WXFCFKclxTU_evR9XJzGuMaYUSHpi-KYUS6lqthJkX5M4dPltys0TmEICSKKMEYXSxNjsM4kaBF4C-PK9GE0abVFzqPBWUDNFrVmGME7v0RpBcgNw8YDMja5O5e2KHRo2J2C6dHikr9Ht8hC38eXxfPO9BFe3a9nxc-rz7eLr-XN9y_Xi4ub0grJUikJNqRhQJkCw1RlVId5y6XohOWSNJyJFncUU2ka2hJVNaIGgSWXkJWdYGfF9Z7bBrPW4-QGM211ME7vNsK01GZKzvagucCqy7fhqjZcsroxgjUtqTMf2qZTmfVxzxo3zQCtBZ8m0x9AD0-8W-lluNOKCkU5zoB394Ap_NpATHpwcW6H8RA2UWdNNXsRPEvfPpGuw2byuVVZRbgSnAr2V7U02YDzXcj32hmqLyRVTNK6mv_7_B-qPFrIr5gD1bm8f1Dw5rHRPw4fMpMF1V5gpxDjBJ22Lpnkwuzb9ZpgPcdT7-Opczz1Lp567gF9UvpA_0_RbzBh5W0 |
CitedBy_id | crossref_primary_10_1007_s12640_023_00655_2 crossref_primary_10_3389_fnins_2021_665757 crossref_primary_10_1007_s12035_020_02113_y crossref_primary_10_1016_j_intimp_2023_110448 crossref_primary_10_1186_s10020_023_00621_w crossref_primary_10_1126_sciadv_abj2797 crossref_primary_10_1096_fj_202101558R crossref_primary_10_1016_j_clim_2024_110206 crossref_primary_10_1186_s13019_024_03038_6 crossref_primary_10_3389_fcvm_2021_747467 crossref_primary_10_1155_2022_3777351 crossref_primary_10_1136_lupus_2022_000836 crossref_primary_10_1161_JAHA_122_028198 crossref_primary_10_1016_j_cellimm_2022_104545 crossref_primary_10_1002_ibra_12055 crossref_primary_10_1155_2021_6652846 crossref_primary_10_1016_j_clim_2023_109880 crossref_primary_10_2147_JIR_S387127 crossref_primary_10_3390_jcm12134309 crossref_primary_10_1016_j_fmre_2022_10_002 crossref_primary_10_1021_acschemneuro_3c00180 crossref_primary_10_3389_fmicb_2024_1337994 crossref_primary_10_1002_adhm_202301325 crossref_primary_10_1016_j_expneurol_2023_114521 crossref_primary_10_3389_fimmu_2023_1155333 crossref_primary_10_1016_j_brainresbull_2022_09_007 crossref_primary_10_1080_14737175_2023_2250917 crossref_primary_10_1016_j_neuropharm_2022_109382 crossref_primary_10_1096_fj_202301140RR crossref_primary_10_1016_j_expneurol_2023_114646 crossref_primary_10_1016_j_neuropharm_2024_110285 crossref_primary_10_3389_fcell_2021_691648 crossref_primary_10_3389_fmed_2023_1265398 crossref_primary_10_1016_j_intimp_2021_108332 |
Cites_doi | 10.1096/fj.201901905RR 10.1038/npp.2016.100 10.1016/S0306-4530(03)00088-X 10.1523/JNEUROSCI.5123-04.2005 10.1007/s10753-015-0175-4 10.1016/j.bbi.2019.05.038 10.4049/jimmunol.1601546 10.1038/protex.2014.030 10.4161/viru.26083 10.1186/s40635-016-0091-4 10.1038/ncomms14919 10.1038/s41398-017-0015-4 10.1007/s00134-017-4807-z 10.1084/jem.20091419 10.1007/s12640-019-00081-3 10.1016/j.bbi.2010.01.001 10.1093/bja/aem201 10.1097/00003246-199008000-00001 10.1016/S0165-5728(98)00193-3 10.1002/glia.23553 10.1016/S0165-6147(99)01419-4 10.1038/nm.2106 10.1186/1471-2253-14-45 10.1016/j.jneuroim.2018.08.013 10.1016/j.bbi.2011.08.005 10.1186/s13054-017-1643-z 10.1016/j.bbi.2014.07.007 10.1177/1179573519840652 10.1186/s12974-020-1701-3 10.1007/s12028-009-9289-6 10.1038/srep27171 10.3389/fpsyt.2018.00776 10.1002/cyto.990140614 10.1016/j.cyto.2020.155049 10.1038/nature18626 10.1186/s12974-020-01759-8 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12974-020-01850-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1742-2094 |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_4507fa1b089a4639ba53bd190f2edbf7 PMC7257240 A627362987 32466783 10_1186_s12974_020_01850_0 |
Genre | Journal Article |
GeographicLocations | China United States--US |
GeographicLocations_xml | – name: China – name: United States--US |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81771354 and 81471106 – fundername: National Natural Science Foundation of China grantid: 81873770 – fundername: ; grantid: 81771354 and 81471106; 81873770 |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M CGR CUY CVF ECM EIF NPM PMFND 3V. 7T5 7TK 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-610a1b3e237ea378a7f04d465f5c461b435d0f2026ab2d178b59e50646e7f0f53 |
IEDL.DBID | 7X7 |
ISSN | 1742-2094 |
IngestDate | Wed Aug 27 01:31:17 EDT 2025 Thu Aug 21 14:10:06 EDT 2025 Thu Jul 10 20:02:09 EDT 2025 Fri Jul 25 03:48:00 EDT 2025 Tue Jun 17 21:25:59 EDT 2025 Tue Jun 10 20:41:39 EDT 2025 Thu Apr 03 07:09:36 EDT 2025 Tue Jul 01 02:54:32 EDT 2025 Thu Apr 24 22:53:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Sepsis CD4+ T cells Monoclonal antibody Meningeal immunity Encephalopathy Brain-derived neurotrophic factor precursor |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-610a1b3e237ea378a7f04d465f5c461b435d0f2026ab2d178b59e50646e7f0f53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2414754253?pq-origsite=%requestingapplication% |
PMID | 32466783 |
PQID | 2414754253 |
PQPubID | 55345 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4507fa1b089a4639ba53bd190f2edbf7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7257240 proquest_miscellaneous_2408202654 proquest_journals_2414754253 gale_infotracmisc_A627362987 gale_infotracacademiconefile_A627362987 pubmed_primary_32466783 crossref_citationtrail_10_1186_s12974_020_01850_0 crossref_primary_10_1186_s12974_020_01850_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-05-28 |
PublicationDateYYYYMMDD | 2020-05-28 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of neuroinflammation |
PublicationTitleAlternate | J Neuroinflammation |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | SL Devos (1850_CR23) 2013; 75 HK Teng (1850_CR13) 2005; 25 AJ Filiano (1850_CR39) 2016; 535 1850_CR24 CHARLES L. SPRUNG (1850_CR4) 1990; 18 N Quan (1850_CR11) 1999; 93 N Derecki (1850_CR20) 2014 R Sonneville (1850_CR2) 2017; 43 O Piazza (1850_CR1) 2007; 99 F Zhong (1850_CR19) 2018; 9 1850_CR6 1850_CR7 H Schweighöfer (1850_CR8) 2016; 4 TM Brombacher (1850_CR12) 2017; 198 YY Bai (1850_CR18) 2016; 41 EA Said (1850_CR36) 2010; 16 A Louveau (1850_CR25) 2015 D Kranjac (1850_CR33) 2012; 26 MP Fink (1850_CR32) 2014; 5 NC Derecki (1850_CR10) 2010; 207 DC Nascimento (1850_CR31) 2017; 8 CA Thomson (1850_CR35) 2020; 17 I Wong (1850_CR38) 2010; 24 J Trivedi (1850_CR34) 2020; 129 FS Taccone (1850_CR5) 2010; 12 HP Düsedau (1850_CR14) 2019; 67 JK Nicholson (1850_CR22) 1993; 14 V Brinkmann (1850_CR27) 2000; 21 DC Nwafor (1850_CR28) 2019; 11 C Pierrakos (1850_CR3) 2014; 14 Z Wang (1850_CR16) 2019; 36 WY Shen (1850_CR21) 2020; 34 R Gao (1850_CR17) 2015; 38 M Satomoto (1850_CR26) 2017; 17 C Ren (1850_CR9) 2020; 17 C Luo (1850_CR15) 2016; 6 XE Xu (1850_CR29) 2019; 80 ST Anderson (1850_CR30) 2015; 43 L Zhou (1850_CR37) 2018; 7 |
References_xml | – volume: 34 start-page: 2541 year: 2020 ident: 1850_CR21 publication-title: FASEB J doi: 10.1096/fj.201901905RR – volume: 41 start-page: 2882 issue: 12 year: 2016 ident: 1850_CR18 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2016.100 – volume: 75 year: 2013 ident: 1850_CR23 publication-title: J Vis Exp – volume-title: Kipnis J year: 2015 ident: 1850_CR25 – ident: 1850_CR24 doi: 10.1016/S0306-4530(03)00088-X – volume: 25 start-page: 5455 issue: 22 year: 2005 ident: 1850_CR13 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5123-04.2005 – volume: 38 start-page: 1949 issue: 5 year: 2015 ident: 1850_CR17 publication-title: Inflammation doi: 10.1007/s10753-015-0175-4 – volume: 80 start-page: 859 year: 2019 ident: 1850_CR29 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2019.05.038 – volume: 17 start-page: 192 year: 2017 ident: 1850_CR26 publication-title: Exp Anim – volume: 198 start-page: 2681 issue: 7 year: 2017 ident: 1850_CR12 publication-title: J Immunol doi: 10.4049/jimmunol.1601546 – volume-title: Mouse meninges isolation for FACS year: 2014 ident: 1850_CR20 doi: 10.1038/protex.2014.030 – volume: 5 start-page: 143 issue: 1 year: 2014 ident: 1850_CR32 publication-title: Virulence doi: 10.4161/viru.26083 – volume: 4 start-page: 19 issue: 1 year: 2016 ident: 1850_CR8 publication-title: Intensive Care Med Exp doi: 10.1186/s40635-016-0091-4 – volume: 8 start-page: 14919 issue: 1 year: 2017 ident: 1850_CR31 publication-title: Nat Commun doi: 10.1038/ncomms14919 – volume: 7 start-page: 1 issue: 11 year: 2018 ident: 1850_CR37 publication-title: Transl Psychiatry doi: 10.1038/s41398-017-0015-4 – volume: 43 start-page: 1 issue: 8 year: 2017 ident: 1850_CR2 publication-title: Intensive Care Med doi: 10.1007/s00134-017-4807-z – volume: 207 start-page: 1067 issue: 5 year: 2010 ident: 1850_CR10 publication-title: J Exp Med doi: 10.1084/jem.20091419 – volume: 36 start-page: 540 issue: 3 year: 2019 ident: 1850_CR16 publication-title: Neurotox Res doi: 10.1007/s12640-019-00081-3 – volume: 24 start-page: 585 issue: 4 year: 2010 ident: 1850_CR38 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2010.01.001 – volume: 99 start-page: 518 issue: 4 year: 2007 ident: 1850_CR1 publication-title: Br J Anaesth doi: 10.1093/bja/aem201 – volume: 18 start-page: 801 issue: 8 year: 1990 ident: 1850_CR4 publication-title: Critical Care Medicine doi: 10.1097/00003246-199008000-00001 – volume: 93 start-page: 72 issue: 1-2 year: 1999 ident: 1850_CR11 publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(98)00193-3 – volume: 67 start-page: 193 issue: 1 year: 2019 ident: 1850_CR14 publication-title: Glia doi: 10.1002/glia.23553 – volume: 21 start-page: 49 issue: 2 year: 2000 ident: 1850_CR27 publication-title: Trends Pharmacol Sci doi: 10.1016/S0165-6147(99)01419-4 – volume: 16 start-page: 452 issue: 4 year: 2010 ident: 1850_CR36 publication-title: Nat Med doi: 10.1038/nm.2106 – volume: 14 start-page: 45 issue: 1 year: 2014 ident: 1850_CR3 publication-title: BMC Anesthesiol doi: 10.1186/1471-2253-14-45 – ident: 1850_CR6 doi: 10.1016/j.jneuroim.2018.08.013 – volume: 26 start-page: 109 issue: 1 year: 2012 ident: 1850_CR33 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2011.08.005 – ident: 1850_CR7 doi: 10.1186/s13054-017-1643-z – volume: 43 start-page: 98 year: 2015 ident: 1850_CR30 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2014.07.007 – volume: 11 start-page: 117957351984065 year: 2019 ident: 1850_CR28 publication-title: J Central Nerv Syst Disease doi: 10.1177/1179573519840652 – volume: 17 start-page: 1 issue: 1 year: 2020 ident: 1850_CR9 publication-title: J Neuroinflammation doi: 10.1186/s12974-020-1701-3 – volume: 12 start-page: 35 issue: 1 year: 2010 ident: 1850_CR5 publication-title: Neurocrit Care doi: 10.1007/s12028-009-9289-6 – volume: 6 start-page: 27171 issue: 1 year: 2016 ident: 1850_CR15 publication-title: Sci Rep doi: 10.1038/srep27171 – volume: 9 start-page: 776 year: 2018 ident: 1850_CR19 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2018.00776 – volume: 14 start-page: 685 issue: 6 year: 1993 ident: 1850_CR22 publication-title: Cytometry doi: 10.1002/cyto.990140614 – volume: 129 start-page: 155049 year: 2020 ident: 1850_CR34 publication-title: Cytokine doi: 10.1016/j.cyto.2020.155049 – volume: 535 start-page: 425 issue: 7612 year: 2016 ident: 1850_CR39 publication-title: Nature doi: 10.1038/nature18626 – volume: 17 start-page: 94 issue: 1 year: 2020 ident: 1850_CR35 publication-title: J Neuroinflammation doi: 10.1186/s12974-020-01759-8 |
SSID | ssj0032562 |
Score | 2.4510965 |
Snippet | Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate... Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to... Abstract Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 169 |
SubjectTerms | Animals Antibodies Brain Brain-derived neurotrophic factor Brain-Derived Neurotrophic Factor - immunology Brain-Derived Neurotrophic Factor - metabolism Brain-derived neurotrophic factor precursor CD4 antigen CD4 lymphocytes CD4+ T cells CD4-Positive T-Lymphocytes - immunology Cognitive ability Complications and side effects Development and progression Encephalopathy Fear conditioning Flow cytometry FTY720 Gene expression Health aspects Homeostasis Immune response Immune system Inflammation Injection Interleukin 13 Laboratory animals Lipopolysaccharides Lipopolysaccharides - toxicity Lymphocytes Lymphocytes T Male Memory Meningeal immunity Meninges Meninges - immunology Mice Mice, Inbred C57BL Monoclonal antibodies Monoclonal antibody Mortality Nervous system Noise Pathogenesis Peripheral blood Physiological aspects Protein Precursors - immunology Protein Precursors - metabolism Sepsis Sepsis-Associated Encephalopathy - chemically induced Sepsis-Associated Encephalopathy - immunology Sepsis-Associated Encephalopathy - metabolism Splenocytes Studies |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLadOX26SoUOghmNiyHvYxjy6hkNBDArmJkSyRhdRe4s0h_74zsndZU2gvvfhgjYw1D803tmaGsa9VE3REqEqVH2UunXN5A43HmKfw0fsowVOi8OWVvriRP27V7U6rLzoTNpYHHhl3LBGwRChdUTcg0Z06UJVr0Y1FEVoXUx45-rxNMDXuwRU6crFJkan18YBezcicQqUCHRReZ24oVev_c0_ecUrzA5M7Hmjxir2coCM_GV_5NXsWun32_HL6Of6GrX8-9KfnVwu-SkfswsCHsBqWQw6TCELLyY5Xd3DfUyfiJ77sOLWj5-6Jt4AAmj6ScISEfElpI4FT1gM1l-B95L_SKOJKfnYuj_g1p2_-w1t2s_h-fXaRT00Vcq90tcZQsUBuVkFUJkBlajCxkK3UKiovdekQPrXIWwzNwIm2NLVTTaCqdjogZVTVO7bX9V34wLjQrmlF7ZU3IKNRoAx4KAPIEKCQJmPlhsfWTxXHqfHFvU2RR63tKBeLcrFJLrbI2NF2zmqst_FX6lMS3ZaSamWnG6hBdtIg-y8Nytg3Erwli8bX8zAlJuAiqTaWPdEI8bRoaqQ8mFGiJfr58EZ17LQTDBYRkqQuw6rK2JftMM2k021d6B-JhoCY0Epm7P2oadslIeDVCChwtpnp4GzN85FueZfqhBvcjvHRH_8Hkz6xFyKZj8pFfcD21g-P4RDh2Np9Tpb3Gy3sMXQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBddB2MvY9_L1g0NBnso3mxZH_bDGP1YKIOUPTTQNyHJUhvI7CxOYfnvd6fYpmalL3mITkHy3fl-F-nuR8invPQyAFTFzo884dbapDSlg5wndcG5wI3DQuHZuTyb85-X4nKP9HRH3QNs70ztkE9qvl5--ftn-x0c_lt0-EJ-bSFmKZ5gIpRC-IHPB-QhRCaFjAYzPpwq5BDeWV84c-e8UXCKPfz_f1PfClXja5S34tL0KXnSAUp6tLOAZ2TP18_Jo1l3ZP6CbH6tm-PT8yldxYt3vqWtX7WLNjGdYnxF0btX12bZID_xli5qiiT11G5pZQBW418nFIAiXWAxiadYC4GUE7QJ9HccBbRJT075Ib2geBLQviTz6Y-Lk7Oko1pInJD5BhLI1GQ29yxX3uSqMCqkvOJSBOG4zCyAqioNDBI2Y1mVqcKK0mOvO-lBMoj8Fdmvm9q_IZRJW1ascMIpw4MSRijjTOYN996kXE1I1j9j7bo-5EiHsdQxHymk3ulFg1501ItOJ-RwmLPadeG4V_oYVTdIYgft-EWzvtKdQ2oOQDjAntOiNBxgmjUitxXAo8B8ZQMs8zMqXqPlwfKc6coVYJPYMUsfSQB-kpUFSB6MJME_3Xi4Nx3dm7cG6-TIPSzyCfk4DONMvPNW--YGZRCeMSn4hLzeWdqwJYDBEmAGzFYjGxzteTxSL65j93AFL2n46bf3L-sdecyiY4iEFQdkf7O-8e8Bfm3sh-hT_wDpCyum priority: 102 providerName: Scholars Portal |
Title | ProBDNF promotes sepsis-associated encephalopathy in mice by dampening the immune activity of meningeal CD4+ T cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32466783 https://www.proquest.com/docview/2414754253 https://www.proquest.com/docview/2408202654 https://pubmed.ncbi.nlm.nih.gov/PMC7257240 https://doaj.org/article/4507fa1b089a4639ba53bd190f2edbf7 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY99L1wUNBnsopo6sD_tpNG1DGSSU0ULehCRLa6Czszh96H_fO0XJagZ98UN0CpLvTve7s-6OkG9F5WUAqIqVH3nGrbVZZSoHPk_ugnOBG4eJwtOZvLjmP-dingJuXbpWuT0T40Fdtw5j5MdgaTh2axXFj-XfDLtG4dfV1ELjOdnH0mUo1Wq-c7gKMOdsmyhTyuMObJviGTpMOZgpePaMUazZ___J_Mg09a9NPrJDk9fkVQKQ9GTD8TfkmW_ekhfT9In8HVlfrtrx2WxCl_Gine9o55fdostMYoSvKWrz8sbcttiP-J4uGopN6am9p7UBGI2hEgrAkC4wecRTzH3AFhO0DfRPHAV0SU_P-BG9ohj5796T68n51elFllorZE7IYg0OY25GtvCsUN4UqjQq5LzmUgThuBxZAFF1Hhg4aMayeqRKKyqPte2kB8ogig9kr2kb_4lQJm1Vs9IJpwwPShihjDMjb7j3JudqQEbbd6xdqjuO7S9udfQ_Sqk3fNHAFx35ovMBOdrNWW6qbjxJPUbW7SixYnb8oV391kkBNQfgG2DPeVkZDrDMGlHYGuBQYL62AZb5HRmvUa9hec6k9ATYJFbI0icSgJ5kVQmUhz1K0EfXH96Kjk7nQaf_Se-AfN0N40y849b49g5pEI4xKfiAfNxI2m5LAHslwAqYrXoy2Ntzf6RZ3MRq4QoOZfjrg6eX9Zm8ZFExRMbKQ7K3Xt35LwC31nYYdWpI9sfns8tfwxi0gOeUlw_doCvp |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLemIQEXxPcKA4wE4jBFSx1_JAeEtpWqY2vFoZN2M7Zjs0pbUppOqP8UfyPvpUlZhLTbLj3Ez5Wd9_V7sd97hHxIMi8DQFWs_Mgjbq2NMpM5iHliF5wL3DhMFB5P5OiMfzsX51vkT5sLg9cqW5tYG-q8dPiNfB88DcdurSL5Mv8VYdcoPF1tW2isxeLEr35DyFZ9Ph4Afz8yNvw6PRpFTVeByAmZLCFWik3fJp4lyptEpUaFmOdciiAcl30L-CGPA4PYxFiW91VqReaxrJv0QBmwSwSY_HvgeGMM9tT5JsBLAD6wNjEnlfsV-FLFIwzQYnCL8NtxfnWPgP89wQ1X2L2mecPvDR-TRw1gpQdrCXtCtnzxlNwfN0fyz8jy-6I8HEyGdF5f7PMVrfy8mlWRaRjvc4rWY35hLkvsf7yis4JegX2idkVzA7AdP81QAKJ0hskqnmKuBba0oGWgV_UooFl6NOB7dErxpKF6Ts7u5KW_INtFWfgdQpm0Wc5SJ5wyPChhhDLO9L3h3puYqx7pt-9Yu6bOObbbuNR1vJNKveaLBr7omi867pG9zZz5usrHrdSHyLoNJVborh-Ui5-6UXjNAWgH2HOcZoYDDLRGJDYH-BWYz22AZX5Cxmu0I7A8Z5p0CNgkVuTSBxKApWRZCpS7HUrQf9cdbkVHN_an0v-0pUfeb4ZxJt6pK3x5jTQI_5gUvEderiVtsyWA2RJgDMxWHRns7Lk7Uswu6urkCpwA_PWr25f1jjwYTcen-vR4cvKaPGS1koiIpbtke7m49m8A6i3t21q_KPlx1wr9F7mrY-c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ProBDNF+promotes+sepsis-associated+encephalopathy+in+mice+by+dampening+the+immune+activity+of+meningeal+CD4%2B+T+cells&rft.jtitle=Journal+of+neuroinflammation&rft.au=Ru-Yi+Luo&rft.au=Luo%2C+Cong&rft.au=Zhong%2C+Feng&rft.au=Wei-Yun%2C+Shen&rft.date=2020-05-28&rft.pub=BioMed+Central&rft.eissn=1742-2094&rft.volume=17&rft.spage=1&rft_id=info:doi/10.1186%2Fs12974-020-01850-0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon |